Viable Tumor Samples Market: Increased Prevalence of Cancer to Augment Market Growth

Viable tumor samples Market – Global Industry Size, Share, Trends, Analysis, And Forecasts 2016 – 2024” by Transparency Market Research is the newest addition to its repository of diverse and extensive market research studies. The said market intelligence report dissects and gauges each of the facets of the international market landscape of the viable tumor samples. The research publication offers an all-inclusive assessment of the international viable tumor samples market with help from detailed insights associated with the viable tumor samples market.

Scientists extensively make utilization of viable tumor cells for in vitro research studies pertaining to the molecular pathways, genetic origins of various diseases like cancer. These samples of viable tumor set good instances of wholly processed tissues that are extensively utilized for the purpose of basic oncology disease research and for the purpose of drug development also.

The international market for viable tumor samples has been categorized into end-user, cancer type, application, and method of storage. Taking the category of end-use, the said market has been divided into cell banks, hospitals/clinics, research/academic institutes, diagnostic labs, and others. By the category of cancer type, the market is classified into stem cells, breast cancer, carcinomas, prostate cancer, leukemia, lymphomas, melanomas, liver cancer, lung cancer, and sarcomas. Based on application type, it is divided into visualization of cell or tissue structure, drug target discovery and drug testing, genetic studies, biomarker validation and/or identification, stem cells cancer related studies and others. And on the basis of methods of storage, dissociated tumor cells, flash frozen tumor samples, Paraffin Embedded (FPFE) method, Formalin-Fixed, fresh tumor samples, and sample processing methods of various other special tumor comprise the segment.

Some of the prominent players that adorn the world market for viable tumor samples are Miltenyi Biotec, Crown Bioscience, Inc., Indivumed GmbH, Conversant Bio, Fluxion Biosciences, StoreMyTumor, and Cureline, Inc.

Request to View Brochure of Report:

Leave a Reply